Hormonal clues may unlock better detection of pregnancy diabetes

NCT ID NCT07652554

Completed Knowledge-focused Sponsor: Pirogov Russian National Research Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study investigates the role of hormonal and metabolic disorders in the development of gestational diabetes mellitus (GDM). Researchers are analyzing data from over 600 pregnant women to identify risk factors and markers that could predict adverse outcomes for both mother and baby. The study involves monitoring blood sugar levels and other clinical measures to better understand how GDM develops and progresses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could identify early markers and risk factors for gestational diabetes, potentially improving screening and management strategies.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to new therapies, and findings may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS (GDM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES MELLITUS (GDM)

Contacts and locations

Locations

State clinical hospital named after V.P. Demikhov

Moscow, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.